CHICAGO (Reuters) - Johnson & Johnson faces a potentially more damaging and costly sequel to the $3 billion recall of its ASR all-metal artificial hips two years ago, one of the most expensive medical ...
Sept 15 (Reuters) - An executive at Johnson & Johnson's DePuy Orthopaedics Inc unit on Monday defended the company's assessment of safety risks associated with metal-on-metal Pinnacle hip implants in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback